Asthma and HBOT

By Dr. James M.D. U.K. Oxygen is a powerful anti-inflammatory agent and asthma has been successfully treated by oxygen, especially at increased atmospheric pressure. The Russians presented data on the successful treatment of asthma in the International Congress Moscow 1981. Over the last 19 years operating high dosage oxygen therapy in the community many patients with MS in our charity […]

Continue reading »

Hyperbaric Oxygen Treatment on a Parkinson’s Disease Patient: A Case Study

Hoggard ML, Johnson KE and Shirachi DY. Chico Hyperbaric Center, Chico, CA 95926 and Department of Physiology and Pharmacology, T. J. Long School of Pharmacy, University of the Pacific, Stockton, CA 95207, USA. INTRODUCTION Parkinson’s Disease (PD) is a chronic neurodegenerative disorder, which is characterized by the loss of dopaminergic neurons whose cell bodies are located in the substantia nigra […]

Continue reading »

One-Two Punch: Glutathione and HBOT

By Julian Whitaker, MD Parkinson’s disease is caused by the degeneration of neurons in the area of the brain that manufactures dopamine, a neurotransmitter that affects movement. As dopamine production drops, characteristic tremors and speech, balance, and motor problems develop. The primary treatment for Parkinson’s is drugs that replace or mimic dopamine, and though these meds improve symptoms, they do not slow disease […]

Continue reading »

Anti-Aging Properties of Hyperbaric Oxygenation

By R.A. Neubauer, M.D. Medical Director, Ocean Hyperbaric Neurologic Center Lauderdale-by-the-Sea, Florida BACKGROUND On the phylogenetic scale, all mammals live to be 7 times their age of skeletal maturity. Man’s age of skeletal maturity is 20 years. In biblical times Methuselah lived to be 900 years of age. (Either related to the method of time measurement or a possible higher […]

Continue reading »

Mild Hyperbaric Therapy As An Immune Modulator

Gunnar Heuser, M.D., Ph.D., Olga Aguilera, M.D., Sylvia Heurser, M.A., Shayna Kasbee, B.A., and Tanya Peach, B.S. Mild Hyperbaric Oxygen treatment (mHBO) in a portable chamber, at 1.3 ATA and 24% oxygen, administered daily for ten consecutive sessions (1 hour each) improves brain function as measured by SPECT brain scan and a test for attention and reaction time. Patients often […]

Continue reading »
1 8 9 10